Antibiotic use is associated with SJ syndrome and toxic epidermal necrosis, with sulfonamides being the most common culprits.

Todays Updates

How to Set a Biologic Strategy for Asthma, with Sara Assaf, MD Sara Assaf, MD

Assaf shares insights into how to navigate patient profiles and treatment options to optimize severe asthma care with biologics.

Natalizumab Biosimilar Officially Launched in the United States Marco Meglio

Natalizumab-sztn is an FDA-approved monotherapy for all indications of the reference product natalizumab, including relapsing forms of multiple sclerosis and Crohn disease.

GLP-1 Semaglutide Fails to Outperform Placebo in Phase 3 EVOKE Trial of Alzheimer Disease Isabella Ciccone, MPH

Results from the EVOKE and EVOKE+ phase 3 studies reported that oral semaglutide did not significantly reduce clinical progression in patients with early symptomatic Alzheimer disease.

FDA Approves New Intrathecal Administration Route for Spinal Muscular Atrophy Gene Therapy Marco Meglio

The FDA has approved Novartis’ intrathecal formulation of onasemnogene abeparvovec-brve, marketed as Itvisma, for patients ages 2 years and older living with spinal muscular atrophy.

Study Identifies Environmental Risk Factors Significantly Associated With Neuromyelitis Optica Spectrum Disorder Isabella Ciccone, MPH

Findings revealed that vitamin D deficiency was associated with an increased risk of NMOSD in East Asian populations, whereas the effect of smoking among Caucasians and other populations was inconsistent.

Advancing DM1 and DMD Care: Insights on DYNE-101 and DYNE-251 Development Marco Meglio

Doug Kerr, MD, PhD, chief medical officer at Dyne Therapeutics, discusses the clinical development of DYNE-101 for myotonic dystrophy type 1 and DYNE-251 for Duchenne muscular dystrophy.

Discussing New Topical Drugs for Atopic Dermatitis in Younger Patients, With Peter Lio, MD Peter Lio, MD

This Fall Clinical Dermatology Conference interview features Peter Lio, MD, discussing takeaways from several of his sessions at the meeting.

Todays Updates

How to Set a Biologic Strategy for Asthma, with Sara Assaf, MD Sara Assaf, MD

Assaf shares insights into how to navigate patient profiles and treatment options to optimize severe asthma care with biologics.

Natalizumab Biosimilar Officially Launched in the United States Marco Meglio

Natalizumab-sztn is an FDA-approved monotherapy for all indications of the reference product natalizumab, including relapsing forms of multiple sclerosis and Crohn disease.

GLP-1 Semaglutide Fails to Outperform Placebo in Phase 3 EVOKE Trial of Alzheimer Disease Isabella Ciccone, MPH

Results from the EVOKE and EVOKE+ phase 3 studies reported that oral semaglutide did not significantly reduce clinical progression in patients with early symptomatic Alzheimer disease.

FDA Approves New Intrathecal Administration Route for Spinal Muscular Atrophy Gene Therapy Marco Meglio

The FDA has approved Novartis’ intrathecal formulation of onasemnogene abeparvovec-brve, marketed as Itvisma, for patients ages 2 years and older living with spinal muscular atrophy.

Study Identifies Environmental Risk Factors Significantly Associated With Neuromyelitis Optica Spectrum Disorder Isabella Ciccone, MPH

Advancing DM1 and DMD Care: Insights on DYNE-101 and DYNE-251 Development Marco Meglio

Doug Kerr, MD, PhD, chief medical officer at Dyne Therapeutics, discusses the clinical development of DYNE-101 for myotonic dystrophy type 1 and DYNE-251 for Duchenne muscular dystrophy.

Discussing New Topical Drugs for Atopic Dermatitis in Younger Patients, With Peter Lio, MD Peter Lio, MD

This Fall Clinical Dermatology Conference interview features Peter Lio, MD, discussing takeaways from several of his sessions at the meeting.

Antibiotic use is associated with SJ syndrome and toxic epidermal necrosis, with sulfonamides being the most common culprits.

Latest News

Make the Diagnosis: This Cyst Is Asymptomatic. Is It a Problem?

Targeted Oral Drug Plus UV Therapy May Help in Extensive Vitiligo

Novel Drug Eases Disease Activity in Dermatomyositis

Biomarker May Flag Humira Responders in Hidradenitis Suppurativa

What Botox Teaches Us About Serendipity in Clinical Encounters

Make the Diagnosis: Are Her Nail Symptoms Part of a Larger Picture?

Todays Updates

How to Set a Biologic Strategy for Asthma, with Sara Assaf, MD Sara Assaf, MD

Natalizumab Biosimilar Officially Launched in the United States Marco Meglio

GLP-1 Semaglutide Fails to Outperform Placebo in Phase 3 EVOKE Trial of Alzheimer Disease Isabella Ciccone, MPH

FDA Approves New Intrathecal Administration Route for Spinal Muscular Atrophy Gene Therapy Marco Meglio

Study Identifies Environmental Risk Factors Significantly Associated With Neuromyelitis Optica Spectrum Disorder Isabella Ciccone, MPH

Advancing DM1 and DMD Care: Insights on DYNE-101 and DYNE-251 Development Marco Meglio

Discussing New Topical Drugs for Atopic Dermatitis in Younger Patients, With Peter Lio, MD Peter Lio, MD

Todays Updates

How to Set a Biologic Strategy for Asthma, with Sara Assaf, MD Sara Assaf, MD

Natalizumab Biosimilar Officially Launched in the United States Marco Meglio

GLP-1 Semaglutide Fails to Outperform Placebo in Phase 3 EVOKE Trial of Alzheimer Disease Isabella Ciccone, MPH

FDA Approves New Intrathecal Administration Route for Spinal Muscular Atrophy Gene Therapy Marco Meglio

Study Identifies Environmental Risk Factors Significantly Associated With Neuromyelitis Optica Spectrum Disorder Isabella Ciccone, MPH

Advancing DM1 and DMD Care: Insights on DYNE-101 and DYNE-251 Development Marco Meglio

Discussing New Topical Drugs for Atopic Dermatitis in Younger Patients, With Peter Lio, MD Peter Lio, MD

Latest News

News All Time

Novel Drug for Chronic Inducible Urticaria Delivers in Mid-Stage Trial

Dupilumab Proves Effective in Chronic Spontaneous Urticaria

50 Years After City Halted Prison Medical Testing, Families Seek Reparations

Make the Diagnosis: She Feels Fine, But Why Do Her Fingers Look Like This?

A Look at Kamala Harris' Medical History

Selective Role for Single-Agent Ipilimumab After Anti-PD-1 Failure in Melanoma

Acne Treatments Taken Right Off the Shelf Had High Levels of Benzene

Make the Diagnosis: It’s Ugly, and It Hurts. What the Heck Is It?

Hitting Psoriatic Arthritis Early With Apremilast Helps Some Patients, Trial Finds

Lebrikizumab Wins FDA Approval for Eczema

Higher Steroid Dose for ICI Toxicity Harms Cancer Survival, Analysis Suggests

Stopping JAK Inhibitor for Severe Alopecia Areata Led to Hair Loss

IL-31 Drug for Itchy Nodular Skin Disease Gets Thumbs Up From FDA

IL-2 Receptor-Targeted Therapy Approved for Relapsed/Refractory CTCL

Psoriasis Control Maintained Long Term With Extended Dosing Interval of Guselkumab

Common Antibiotics Linked With Serious Skin Reactions in Older Adults

Recommended News For You

In a recent study, Kencur ginger's anti-cancer properties were discovered.

Mammo Responsibility Increases Screening; Opioids for Pain Related to Cancer? Ignored CRC Signs.

FDA Approves Hemophilia B Second Gene Therapy.

Mutation Clearance After Transplant Linked to Better Outcomes in Myelofibrosis

Study: Rapamycin slows the progression of cancer by reducing aging and concentrating on precancerous cells.

Depression risk higher among long-term breast cancer survivors than women without breast cancer history

Research team uncovers the underpinnings of head and neck cancers

Recommended Articles For You

Understanding Bone Metastases: How Long Can Someone Live When Cancer Spreads To The Bones?

Understanding Sideroblastic Anemia and its Symptoms

Understanding Neutrophilia: Causes, Symptoms, and Treatment Options

Understanding Protein C Deficiency: Symptoms, Causes, and Treatment

Whats more on Hidoc Dr.

Medical Updates

KOL Videos

Surveys

Events

Featured News

Featured Articles

Featured Events

Featured KOL Videos

Quick Links

Verification

Welcome to Hidoc Dr.